Real ‐world treatment patterns and clinical outcomes after introduction of immune checkpoint inhibitors: Results from a retrospective chart review of patients with advanced/metastatic non‐small cell lung cancer in the EU5

ConclusionsThis study demonstrated differences in treatment patterns and clinical outcomes in NSCLC across the EU5 and patient subgroups. Improved survival was generally associated with response to first-line therapy, nonsquamous histology, and CNS/brain metastases absence. These real-world data provide valuable insights which may aid treatment decision-making and clinical trial design.

Source: Thoracic Cancer - August 18, 2023 Category: Cancer & Oncology Authors: Alexander Slowley, Kelesitse Phiri, Jasjit K. Multani, Vicky Casey, Sheila Mpima, Marie Yasuda, Chi ‐Chang Chen, Fil Manuguid, Jessica Chao, Amine Aziez, Kelly F. Bell, Alexander Stojadinovic Tags: ORIGINAL ARTICLE Source Type: research